INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
Beth Israel Deaconess Medical Center
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Beth Israel Deaconess Medical Center (13)
2022
2020
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, Vol. 52, Núm. 1, pp. 56-73
2017
-
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Nature Genetics, Vol. 49, Núm. 5, pp. 680-691
2015
-
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
JAMA - Journal of the American Medical Association, Vol. 313, Núm. 13, pp. 1347-1361
2014
2013
2012
-
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma
Endocrine-Related Cancer, Vol. 19, Núm. 5, pp. 695-710
2011
-
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers
Human Genetics, Vol. 130, Núm. 5, pp. 685-699
-
Stroke-related translational research
Archives of Neurology, Vol. 68, Núm. 9, pp. 1110-1123
2010
-
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer
PLoS Genetics, Vol. 6, Núm. 10, pp. 1-12
2009
-
Natural Course and Prognosis
Intracranial Atherosclerosis (John Wiley and Sons), pp. 113-124
1995
-
The role of N-glycosylation for functional expression of the human platelet-activating factor receptor. Glycosylation is required for efficient membrane trafficking
Journal of Biological Chemistry, Vol. 270, Núm. 42, pp. 25178-25184